Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
Accessible DAAs Shouldn’t Be DOA: Delivering on the Promise of Negotiated Price Reductions for HCV Treatment
The hepatitis C virus remains one of the deadliest infectious diseases, despite the existence of an effective eight-to-twelve week cure. Access to direct acting antivirals must be urgently expanded to save lives. More
WHO Prequalifies the First Self-Test for Hepatitis C Virus
WHO has prequalified the first HCV self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C. More
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Test Enables Single-Visit Testing and Treatment for Hepatitis C. More
From Principle to Practice: Involving Communities in Research Design for Effective Hepatitis C Prevention
Unitaid’s funding to support the integration of hepatitis C testing and treatment in harm reduction services, while trialing the use of two underused products to prevent infection. More
ECDC: High Burden of Hepatitis B and C Persists in the EU/EEA
Recent ECDC data show that despite progress in prevention and control efforts, hepatitis B and C continue to pose significant public health challenges in the European Union and European Economic Area. More
Digitalized Community-led Monitoring - HIV/HBV/HCV in India and Indonesia
TREAT Asia/amfAR is implementing the Community-led Monitoring in Asia project, an online data dashboard to enhance ongoing community-led monitoring in India and Indonesia, including HBV and HCV indicators. More
Barriers to a Cure: Study Reveals Global Obstacles to Getting Hep C Treatment
A study provides new evidence regarding the registration and reimbursement of HCV therapies, including restrictions on reimbursement, permitting multicountry analyses and highlighting areas for growth. More
Progress Towards Elimination of Viral Hepatitis: a Lancet Gastroenterology & Hepatology Commission Update
The Commission update focuses on national progress among the 20 countries most heavily burdened with viral hepatitis (75% of the global burden). An effective response in these countries is crucial if global elimination targets are to be achieved. More
Driving Progress: Funding Hepatitis Elimination Programs for Lasting Impact
By addressing the funding gap through creative financing mechanisms, we can accelerate the progress towards eliminating hepatitis globally. More
World Health Organization Commends Egypt for its Progress on the Path to Eliminate Hepatitis C
Egypt has become the first country to achieve the “gold tier” status on the path to elimination of hepatitis C as per WHO criteria. More
